These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33457451)

  • 1. Dysregulated PJA1-TGF-β signaling in cancer stem cell-associated liver cancers.
    Chen J; A Gingold J
    Oncoscience; 2020 Nov; 7(11-12):88-95. PubMed ID: 33457451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGFβ Signaling.
    Chen J; Mitra A; Li S; Song S; Nguyen BN; Chen JS; Shin JH; Gough NR; Lin P; Obias V; He AR; Yao Z; Malta TM; Noushmehr H; Latham PS; Su X; Rashid A; Mishra B; Wu RC; Mishra L
    Cancer Res; 2020 May; 80(9):1819-1832. PubMed ID: 32127355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in TGF-β signaling leads to high HMGA2 levels potentially through modulation of PJA1/SMAD3 in HCC cells.
    Ohshiro K; Chen J; Srivastav J; Mishra L; Mishra B
    Genes Cancer; 2020; 11(1-2):43-52. PubMed ID: 32577156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β/β2-spectrin/CTCF-regulated tumor suppression in human stem cell disorder Beckwith-Wiedemann syndrome.
    Chen J; Yao ZX; Chen JS; Gi YJ; Muñoz NM; Kundra S; Herlong HF; Jeong YS; Goltsov A; Ohshiro K; Mistry NA; Zhang J; Su X; Choufani S; Mitra A; Li S; Mishra B; White J; Rashid A; Wang AY; Javle M; Davila M; Michaely P; Weksberg R; Hofstetter WL; Finegold MJ; Shay JW; Machida K; Tsukamoto H; Mishra L
    J Clin Invest; 2016 Feb; 126(2):527-42. PubMed ID: 26784546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired reciprocal regulation between SIRT6 and TGF-β signaling in fatty liver.
    Xiang X; Ohshiro K; Zaidi S; Yang X; Bhowmick K; Vegesna AK; Bernstein D; Crawford JM; Mishra B; Latham PS; Gough NR; Rao S; Mishra L
    FASEB J; 2022 Jun; 36(6):e22335. PubMed ID: 35506565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
    Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E3 ubiquitin ligase PJA1 regulates lung adenocarcinoma apoptosis and invasion through promoting FOXR2 degradation.
    Luo Z; Ye X; Cheng Y; Li F; Shou F; Wang G
    Biochem Biophys Res Commun; 2021 Jun; 556():106-113. PubMed ID: 33839405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 9. Transforming Growth Factor-β Promotes Liver Tumorigenesis in Mice via Up-regulation of Snail.
    Moon H; Ju HL; Chung SI; Cho KJ; Eun JW; Nam SW; Han KH; Calvisi DF; Ro SW
    Gastroenterology; 2017 Nov; 153(5):1378-1391.e6. PubMed ID: 28734833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
    Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
    Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer.
    Rojas A; Zhang P; Wang Y; Foo WC; Muñoz NM; Xiao L; Wang J; Gores GJ; Hung MC; Blechacz B
    Neoplasia; 2016 Jun; 18(6):371-86. PubMed ID: 27292026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development.
    Wu K; Ding J; Chen C; Sun W; Ning BF; Wen W; Huang L; Han T; Yang W; Wang C; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2012 Dec; 56(6):2255-67. PubMed ID: 22898879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of PRAJA and ELF in TGF-beta signaling and gastric cancer.
    Mishra L; Katuri V; Evans S
    Cancer Biol Ther; 2005 Jul; 4(7):694-9. PubMed ID: 16096365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophin-1-interacting protein 4/human Itch is a ubiquitin E3 ligase for human enhancer of filamentation 1 in transforming growth factor-beta signaling pathways.
    Feng L; Guedes S; Wang T
    J Biol Chem; 2004 Jul; 279(28):29681-90. PubMed ID: 15051726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer.
    Baek HJ; Pishvaian MJ; Tang Y; Kim TH; Yang S; Zouhairi ME; Mendelson J; Shetty K; Kallakury B; Berry DL; Shin KH; Mishra B; Reddy EP; Kim SS; Mishra L
    Hepatology; 2011 May; 53(5):1676-84. PubMed ID: 21520178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling.
    Tang Y; Kitisin K; Jogunoori W; Li C; Deng CX; Mueller SC; Ressom HW; Rashid A; He AR; Mendelson JS; Jessup JM; Shetty K; Zasloff M; Mishra B; Reddy EP; Johnson L; Mishra L
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2445-50. PubMed ID: 18263735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHIP controls the sensitivity of transforming growth factor-beta signaling by modulating the basal level of Smad3 through ubiquitin-mediated degradation.
    Xin H; Xu X; Li L; Ning H; Rong Y; Shang Y; Wang Y; Fu XY; Chang Z
    J Biol Chem; 2005 May; 280(21):20842-50. PubMed ID: 15781469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. βII-Spectrin (SPTBN1) suppresses progression of hepatocellular carcinoma and Wnt signaling by regulation of Wnt inhibitor kallistatin.
    Zhi X; Lin L; Yang S; Bhuvaneshwar K; Wang H; Gusev Y; Lee MH; Kallakury B; Shivapurkar N; Cahn K; Tian X; Marshall JL; Byers SW; He AR
    Hepatology; 2015 Feb; 61(2):598-612. PubMed ID: 25307947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling.
    Torbenson M; Marinopoulos S; Dang DT; Choti M; Ashfaq R; Maitra A; Boitnott J; Wilentz RE
    Hum Pathol; 2002 Sep; 33(9):871-6. PubMed ID: 12378510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.